IFNG and plasma cell myeloma: For instance, a viral construct of CS1-specific CAR, which targets a protein highly expressed in multiple myeloma cells, was successfully used in both in vivo and in vitro studies, resulting in enhanced IFN-γ expression and activated cytolysis of myeloma cells (125).